When are oral corticosteroids indicated for upper or lower respiratory tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Corticosteroids for Respiratory Tract Infections

Oral corticosteroids are indicated for COPD exacerbations (both ambulatory and hospitalized patients) and severe community-acquired pneumonia, but should NOT be used for uncomplicated upper respiratory tract infections, acute bronchitis in non-COPD patients, or viral respiratory infections in otherwise healthy adults.

COPD Exacerbations (Lower Respiratory Tract)

For ambulatory patients with COPD exacerbations, give a short course (≤14 days) of oral corticosteroids 1. The 2017 ERS/ATS guidelines specifically recommend:

  • Dose: 30-40 mg prednisone daily for 5 days 1
  • Duration: Maximum 14 days
  • Benefits: Shortens recovery time, improves lung function and hypoxemia, reduces risk of early relapse and treatment failure 1

For hospitalized COPD patients, oral corticosteroids are preferred over intravenous if gastrointestinal access is intact 1. IV offers no additional benefit and may increase adverse effects and healthcare costs 1.

Key Clinical Considerations for COPD:

  • Episodes with purulent sputum are most likely to benefit 1
  • Emerging evidence suggests patients with blood eosinophil count ≥2% respond better to corticosteroids 1
  • Systemic corticosteroids reduce treatment failure within the first 30 days following exacerbation 2
  • Do NOT use corticosteroids beyond 30 days to prevent future exacerbations—risks outweigh benefits 2

Community-Acquired Pneumonia (Lower Respiratory Tract)

Low-dose corticosteroids (≤400 mg hydrocortisone equivalent daily) reduce mortality in severe community-acquired pneumonia 3, 4:

  • For ICU patients with severe bacterial CAP: hydrocortisone ≤400 mg daily for ≤8 days reduced 30-day mortality from 16% to 10% 3
  • For hospitalized patients with severe CAP: strong recommendation for use 4
  • For septic shock with CAP: hydrocortisone 50 mg IV every 6 hours plus fludrocortisone 50 μg daily for 7 days decreased mortality from 51% to 39% 3

When NOT to Use Oral Corticosteroids

Upper Respiratory Tract Infections

Do NOT use corticosteroids for:

  • Common cold 5
  • Influenza 5
  • Acute pharyngitis
  • Uncomplicated rhinosinusitis 5

Acute Lower Respiratory Tract Infections in Non-Asthmatic Adults

A 2017 multicenter RCT of 398 adults with acute cough and lower respiratory symptoms (without asthma) found NO benefit from 5 days of prednisolone 40 mg daily 6:

  • No reduction in cough duration (5 days in both groups)
  • No reduction in symptom severity
  • Conclusion: Oral corticosteroids should NOT be used for acute lower respiratory tract infections in adults without asthma 6

This finding was confirmed in a 2020 exploratory analysis specifically examining patients with unrecognized asthma—even in this subgroup, corticosteroids provided no benefit 7.

Preschool Children with Wheezing

Post-hoc analyses of two large cohorts found NO benefit from oral corticosteroids for acute wheezing episodes in preschool children 8. Despite widespread use, symptom scores did not differ between treated and untreated episodes.

Exception: One older 1988 study suggested benefit when corticosteroids were given preventively at the first sign of upper respiratory infection in preschool asthmatics (before wheezing developed), reducing attacks by 56% and hospitalizations by 90% 9. However, this approach is not currently standard practice and requires prospective validation.

Critical Illness Scenarios

For critically ill patients with severe pulmonary infections (COVID-19, severe CAP, Pneumocystis pneumonia, ARDS):

  • Dexamethasone 6 mg daily for 10 days reduced 28-day mortality in hospitalized COVID-19 patients requiring oxygen (23% vs 26%) 3
  • Hydrocortisone ≤400 mg daily for ARDS reduced in-hospital mortality (34% vs 45%) 3
  • Strong recommendation for corticosteroids in critically ill patients with ARDS 4

Common Pitfalls to Avoid

  1. Do not use corticosteroids for viral upper respiratory infections—no benefit and potential harm 6, 5
  2. Do not continue corticosteroids beyond 14 days for COPD exacerbations—no evidence of benefit and increased adverse effects 1, 2
  3. Do not use high-dose/short-duration regimens for septic shock—recommended against 4
  4. Do not assume all respiratory infections benefit—the indication is disease-specific (COPD, severe CAP, critical illness), not symptom-based
  5. Avoid IV corticosteroids in hospitalized COPD patients if oral route is available—no added benefit, higher costs 1

Adverse Effects to Monitor

Short-term corticosteroid use carries risks including:

  • Hyperglycemia
  • Weight gain
  • Insomnia
  • Gastrointestinal bleeding
  • Neuropsychiatric effects
  • Muscle weakness
  • Secondary infections 2, 3

These risks are acceptable for proven indications (COPD exacerbations, severe CAP, critical illness) but not justified for conditions where benefit is unproven (uncomplicated respiratory infections) 2, 6.

References

Related Questions

Should an 83-year-old woman with an uncomplicated upper respiratory tract infection and an oxygen saturation of 96% be given oral corticosteroids?
For a patient with an upper respiratory tract infection who was prescribed oral corticosteroids by a primary care physician, can an inhaled corticosteroid combined with albuterol (short‑acting β2‑agonist) be used instead, given a normal oxygen saturation of 96%?
What is the appropriate use of steroids, such as prednisolone, in patients with Lower Respiratory Tract Infections (LRTI), particularly those with a history of respiratory conditions like asthma or Chronic Obstructive Pulmonary Disease (COPD)?
Can inhaled corticosteroids be administered to patients with lower respiratory tract infection presenting with wheeze and rhonchi?
When are steroid shots contraindicated in patients with upper respiratory infections?
For a patient with an upper respiratory tract infection who was prescribed oral corticosteroids by a primary care physician, can an inhaled corticosteroid combined with albuterol (short‑acting β2‑agonist) be used instead, given a normal oxygen saturation of 96%?
What empiric antibiotic regimen should be used to cover Enterococcus faecalis in a patient with community‑ or health‑care‑associated pneumonia?
How many alcoholic beverages (e.g., beers) may a physician consume per hour while on call?
Do hypercholesterolemia and hypertriglyceridemia cause dizziness?
What are the causes of vertigo in an older adult?
What antiepileptic medications are recommended and how should they be dosed for a pregnant woman with epilepsy to minimize fetal risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question